Advertising and promotion of reimbursement for medical devices

On Tuesday 22 February I delivered this presentation at the Q1 2nd Annual European Medical Devices Reimbursement Conference.

My presentation addressed the question of what constraints there are on companies providing information with respect to coverage and reimbursement to customers. There are many, both contained in mandatory law and self-regulatory rules.

It was remarkable to hear how similar and at the same time different national reimbursement systems are in the EU, as for medical devices no harmonisation has taken place yet in the field of reimbursement. For pharmaceuticals there is some in the form of the Transparency Directive. However, the upcoming Cross-Border Healthcare Directive is expected to lead to de facto harmonisation in the field of medical devices as it provides for a legal basis for HTA cooperation, as you will also see explained in brief in my presentation.


Navigate through our knowledgebase

Related articles

Article

Impossible and Incredible And Yet Really Happened

What can we learn from the Impossible vs. Incredible case in the Netherlands? At the end May this year, the Court of The Hague rendered a remarkable judgment: at the request of Impossible Foods, Nestlé was banned from launching its INCREDIBLE BURGER in the EU. How is this possible? Impossible Foods is not even on […]

Article

Standardisation request for MDR and IVDR refused; now what?

A new blog post, a new step in the soap that is the non-transitional period of the MDR and the IVDR. I have jokingly paraphrased the absurdist painter Magritte by saying “céci…

Read more

Article

Standardisation request for MDR and IVDR refused – now what?

A new blog post, a new step in the soap that is the non-transitional period of the MDR and the IVDR. I have jokingly paraphrased the absurdist painter Magritte by saying “céci…

Read more